摘要
目的对小儿咳嗽变异性哮喘的临床诊断和治疗进行探讨和分析。方法随机选取2014年2月—2015年3月期间在该院接受治疗的小儿咳嗽变异性哮喘患儿52例,按照不同的治疗方法平均分为两组,喷雾组患者通过二丙酸培氯米松气雾剂进行治疗,口服组的治疗方法则是服用孟鲁司特钠和盐酸丙卡特罗,将两组患者的治疗效果进行对比,探讨小儿咳嗽变异性哮喘的治疗效果。结果数据结果显示,采用二丙酸培氯米松气雾剂进行治疗的喷雾组(88.5%)患者治疗有效率比口服组患者(96.2%)低,两组数据差异有统计学意义(χ2=6.786,P=0.0012)。结论提高小儿咳嗽变异性哮喘诊断的准确性,从而能够及时有效地治疗;通过服用孟鲁司特钠联合盐酸丙卡特罗治疗小儿咳嗽变异性哮喘临床疗效显著,显效快、复发率低,更适合临床小儿咳嗽变异性哮喘的治疗。
Objective To discuss and analyze clinical diagnosis and treatment of infantile cough variant asthma. Methods 52 patients with infantile cough variant asthma treated in this hospital from February 2014 and March 2015 were randomly selected and divided evenly into two groups according to methods used. Patients in the group were treated with beclomethasone dipropionate aerosol spray group, while those in the oral group were administrated with montelukast and procaterol hydrochloride orally. We compared and discussed the efficacy of the two treatments. Results The efficacy(88.5% vs 96.2%) was lower in the spray group than in the oral group, and the difference was statistically significant(χ2=6.786, P =0.0012). Conclusion Accurate diagnosis is necessary for the timely and effective treatment of infantile cough variant asthma, and for this disease, oral administration of montelukast and procaterol hydrochloride can bring remarkable effect with rapid response and low recurrence rate, and is more suitable.
出处
《中外医疗》
2015年第27期51-52,共2页
China & Foreign Medical Treatment
